AP
Arrowhead Pharmaceuticals Inc
🇺🇸XNAS.ARWRUnited StatesHealthcare
$64.71USDdown -5.94 (-8.41%)ClosedDelayed8:57 PM
Price$64.71-5.94 (-8.41%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US04280A1007
- CUSIP
- 042797100
Company
- Employees
- 711
- Headquarters
- Pasadena, United States
- Website
- https://arrowheadpharma.com
- CEO
- Dr. Christopher R. Anzalone Ph.D.
Market
- Shares outstanding
- 141.3M
- Market cap
- $9.14B
Highlights
- Market cap
- $9.98B
- EPS LTM
- -$2.27calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -28.57calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.69%
Fundamentals (LTM)
- Revenue
- $669.5M+12.22%up year on year
- Net income
- -$319.95M-115.58%down year on year
- Gross margin
- 97.14%+0.96%up year on year
- Free cash flow
- -$75.11M-326.26%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.